+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Advanced Therapy Medicinal Products CDMO Market by Product Type, Service Type, Therapeutic Area, Application, End-User - Global Forecast to 2030- Product Image
Advanced Therapy Medicinal Products CDMO Market by Product Type, Service Type, Therapeutic Area, Application, End-User - Global Forecast to 2030- Product Image
Sale

Advanced Therapy Medicinal Products CDMO Market by Product Type, Service Type, Therapeutic Area, Application, End-User - Global Forecast to 2030

  • PDF Icon

    Report

  • 199 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5665766
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The advanced therapy medicinal products CDMO market is rapidly changing, fueled by ongoing advances in cell therapies, gene editing, and tissue engineering. Industry leaders are navigating a landscape with heightened regulatory requirements, evolving technology, and new competitive pressures, demanding strategic agility in manufacturing and supply chain decisions.

Market Snapshot: Advanced Therapy Medicinal Products CDMO Market

The Advanced Therapy Medicinal Products CDMO market grew from USD 7.71 billion in 2024 to USD 8.97 billion in 2025. The sector is projected to expand steadily at a CAGR of 17.27%, ultimately reaching USD 20.08 billion by 2030. This robust trajectory reflects rising adoption of advanced therapies, strong R&D pipelines, and increased outsourcing by biopharmaceutical firms seeking scalable and compliant manufacturing solutions.

Scope & Segmentation

  • Product Types: Cell therapy products (including non-stem cell and stem cell therapies), gene therapy products (germline and somatic therapies), and tissue engineered products tailored for individualized treatment formats.
  • Service Types: Analytical testing and quality control, manufacturing services, process development, and regulatory and compliance support across clinical and commercial applications.
  • Therapeutic Areas: Oncology, neurology, hematology, cardiology, and dermatology driving innovation and service demand.
  • Application Stages: Clinical-stage and commercial-stage pipelines, encompassing early innovation and large-scale product launches.
  • End-Users: Academic and research institutes collaborating on early-stage projects, and biopharmaceutical companies focused on market expansion.
  • Regions Covered: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including leading pharmaceutical nations and emerging centers), and Asia-Pacific (including China, India, Japan, Australia, and Southeast Asian markets).
  • Technologies & Innovations: Flexible modular facilities, single-use bioreactors, continuous processing, digital quality control platforms, and advanced analytics transforming manufacturing efficiency.
  • Companies Analyzed: Comprehensive review of industry leaders such as Abzena, Catalent Inc., Lonza Group, FUJIFILM Diosynth Biotechnologies, Thermo Fisher Scientific Inc.'s Patheon, Samsung Biologics, and additional regional and niche CDMO providers.

Key Takeaways for Senior Decision-Makers

  • Regulatory evolution aligns with fast-paced innovation in advanced therapies, shaping the entire CDMO services landscape.
  • Integrated end-to-end offerings—such as combined analytical, process development, and compliance services—provide attractive solutions for biopharma partners seeking to accelerate pipeline products.
  • Decentralized manufacturing and modular facility design now feature prominently, driven by needs for flexibility and adaptive scaling in clinical and commercial production alike.
  • Specialized expertise in cellular and gene-modification platforms is a key differentiator among CDMOs, especially for complex or novel therapies targeting hematological and neurological conditions.
  • Collaboration between CDMOs, academic institutions, and technology providers results in faster process development and supports entry into new therapeutic modalities.
  • Proactive investment in digital quality management, supply-chain resilience, and sustainability initiatives positions organizations to adapt swiftly to evolving regulations and market demands.

Tariff Impact and Supply Chain Response

Recently implemented United States tariffs are reshaping sourcing strategies across the ATMP CDMO market. Increased costs for critical raw materials and specialized equipment have compressed manufacturing margins and influenced broader outsourcing and investment strategies. In response, companies are diversifying suppliers, considering nearshore or onshore partnerships, and actively negotiating long-term supply agreements to mitigate cost and policy risks. These changes have led to greater regionalization and prompted detailed reviews of production site allocation, regulatory incentives, and logistical strengths.

Methodology & Data Sources

This analysis leverages primary interviews with senior executives and technical experts, together with secondary research from peer-reviewed journals, industry reports, and financial disclosures. Data triangulation and rigorous validation through expert panels ensure the credibility and actionable insights foundational to this report.

Why This Report Matters

  • Provides strategic clarity on navigating regulatory, supply chain, and market dynamics unique to the advanced therapy medicinal products CDMO sector.
  • Enables informed decision-making by benchmarking current best practices, technology integration, and differentiators across global and regional manufacturing landscapes.
  • Guides resource allocation and partnership evaluation with detailed segment analysis, competitive profiles, and outcome-driven recommendations.

Conclusion

The advanced therapy medicinal products CDMO sector is marked by continuous evolution. Organizations able to anticipate policy changes, adapt technologies, and build collaborative networks will strengthen their market positions in this dynamic field.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Proliferation in prevalence of rare diseases with growing emergence of novel
infectious diseases
5.1.1.2. Rising numbers of clinical trials for development of advanced therapy medicinal products
5.1.1.3. Increasing investments in pharmaceutical research and development worldwide
5.1.2. Restraints
5.1.2.1. High cost associated with outsourcing ATMP solutions
5.1.3. Opportunities
5.1.3.1. Adoption of advanced technologies by advanced therapy medicinal
products CDMOs
5.1.3.2. Strategic alliance and expansion activities for R&D of advanced therapy medicinal products
5.1.4. Challenges
5.1.4.1. Stringent governmental rules and regulations for ATMP approvals and
commercialization
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Advanced Therapy Medicinal Products CDMO Market, by Products
6.1. Introduction
6.2. Cell Therapy
6.3. Gene Therapy
6.4. Tissue Engineered
7. Advanced Therapy Medicinal Products CDMO Market, by Phase
7.1. Introduction
7.2. Phase I
7.3. Phase II
7.4. Phase III
7.5. Phase IV
8. Advanced Therapy Medicinal Products CDMO Market, by Indication
8.1. Introduction
8.2. Cardiology
8.3. Central Nervous System
8.4. Dermatology
8.5. Endocrine, Metabolic, Genetic
8.6. Gastroenterology
8.7. Hematology
8.8. Immunology & Inflammation
8.9. Infectious Disease
8.10. Musculoskeletal
8.11. Oncology
8.12. Ophthalmology
9. Advanced Therapy Medicinal Products CDMO Market, by End-Users
9.1. Introduction
9.2. Academic and Research Institutions
9.3. Biotechnology & Pharmaceutical Companies
9.4. Clinical Research Organizations (CROs)
9.5. Hospitals and Clinics
10. Americas Advanced Therapy Medicinal Products CDMO Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Advanced Therapy Medicinal Products CDMO Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Advanced Therapy Medicinal Products CDMO Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET RESEARCH PROCESS
FIGURE 2. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2023 VS 2030 (%)
FIGURE 7. GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
FIGURE 13. GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET DYNAMICS
TABLE 7. GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY TISSUE ENGINEERED, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE I, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE II, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE III, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE IV, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY ENDOCRINE, METABOLIC, GENETIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY IMMUNOLOGY & INFLAMMATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY MUSCULOSKELETAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS (CROS), BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 46. CANADA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 47. CANADA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 48. CANADA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 49. CANADA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 50. MEXICO ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 51. MEXICO ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 52. MEXICO ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 53. MEXICO ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 68. CHINA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 69. CHINA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 70. CHINA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 71. CHINA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 72. INDIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 73. INDIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 74. INDIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 75. INDIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 76. INDONESIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 77. INDONESIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 78. INDONESIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 79. INDONESIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 80. JAPAN ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 81. JAPAN ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 82. JAPAN ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 83. JAPAN ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 84. MALAYSIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 85. MALAYSIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 86. MALAYSIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 87. MALAYSIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 88. PHILIPPINES ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 89. PHILIPPINES ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 90. PHILIPPINES ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 91. PHILIPPINES ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 92. SINGAPORE ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 93. SINGAPORE ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 94. SINGAPORE ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 95. SINGAPORE ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 96. SOUTH KOREA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 97. SOUTH KOREA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 98. SOUTH KOREA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 99. SOUTH KOREA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 100. TAIWAN ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 101. TAIWAN ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 102. TAIWAN ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 103. TAIWAN ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 104. THAILAND ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 105. THAILAND ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 106. THAILAND ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 107. THAILAND ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 108. VIETNAM ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 109. VIETNAM ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 110. VIETNAM ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 111. VIETNAM ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 117. DENMARK ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 118. DENMARK ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 119. DENMARK ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 120. DENMARK ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 121. EGYPT ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 122. EGYPT ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 123. EGYPT ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 124. EGYPT ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 125. FINLAND ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 126. FINLAND ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 127. FINLAND ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 128. FINLAND ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 129. FRANCE ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 130. FRANCE ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 131. FRANCE ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 132. FRANCE ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 133. GERMANY ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 134. GERMANY ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 135. GERMANY ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 136. GERMANY ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 137. ISRAEL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 138. ISRAEL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 139. ISRAEL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 140. ISRAEL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 141. ITALY ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 142. ITALY ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 143. ITALY ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 144. ITALY ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 145. NETHERLANDS ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 146. NETHERLANDS ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 147. NETHERLANDS ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 148. NETHERLANDS ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 149. NIGERIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 150. NIGERIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 151. NIGERIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 152. NIGERIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 153. NORWAY ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 154. NORWAY ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 155. NORWAY ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 156. NORWAY ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 157. POLAND ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 158. POLAND ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 159. POLAND ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 160. POLAND ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 161. QATAR ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 162. QATAR ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 163. QATAR ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 164. QATAR ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 165. RUSSIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 166. RUSSIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 167. RUSSIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 168. RUSSIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 169. SAUDI ARABIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 170. SAUDI ARABIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 171. SAUDI ARABIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 172. SAUDI ARABIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 173. SOUTH AFRICA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 174. SOUTH AFRICA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 175. SOUTH AFRICA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 176. SOUTH AFRICA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 177. SPAIN ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 178. SPAIN ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 179. SPAIN ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 180. SPAIN ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 181. SWEDEN ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 182. SWEDEN ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 183. SWEDEN ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 184. SWEDEN ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 185. SWITZERLAND ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 186. SWITZERLAND ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 187. SWITZERLAND ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 188. SWITZERLAND ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 189. TURKEY ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 190. TURKEY ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 191. TURKEY ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 192. TURKEY ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 193. UNITED ARAB EMIRATES ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 194. UNITED ARAB EMIRATES ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 195. UNITED ARAB EMIRATES ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 196. UNITED ARAB EMIRATES ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 198. UNITED KINGDOM ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 200. UNITED KINGDOM ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 201. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SHARE, BY KEY PLAYER, 2023
TABLE 202. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET, FPNV POSITIONING MATRIX, 2023

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Advanced Therapy Medicinal Products CDMO market report include:
  • Abzena
  • Advanced Therapies, LLC
  • AGC Inc.
  • Aldevron
  • Almac Group
  • Bio Elpida by Polyplus
  • BlueReg
  • Catalent Inc.
  • CELONIC Group
  • CGT Catapult
  • Charles River Laboratories International, Inc.
  • Coriolis Pharma Research GmbH
  • Curia Global, Inc.
  • Eurofins Scientific SE
  • FUJIFILM Diosynth Biotechnologies
  • Lonza Group
  • Minaris Regenerative Medicine
  • Oxford Biomedica PLC
  • Patheon by Thermo Fisher Scientific Inc.
  • Recipharm AB
  • Rentschler Biopharma SE
  • REPROCELL Inc.
  • RoslinCT
  • Samsung Biologics
  • VIVEBIOTECH S.L.

Table Information

Report AttributeDetails
No. of Pages199
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 8.97 Billion
Forecasted Market Value ( USD ) by 2030 $ 20.08 Billion
Compound Annual Growth Rate17.2%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Advanced Therapy Medicinal Products CDMO Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Advanced Therapy Medicinal Products CDMO Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Market Report 2025 - Product Image

Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Active Pharmaceutical Ingredients CDMO Market by Service Type, Molecule Type, Production Scale, Therapeutic Area, Manufacturing Technology - Global Forecast to 2030 - Product Image

Active Pharmaceutical Ingredients CDMO Market by Service Type, Molecule Type, Production Scale, Therapeutic Area, Manufacturing Technology - Global Forecast to 2030

  • Report
  • 181 Pages
  • Global
From
Cell & Gene Therapy Biomanufacturing CDMO Market by Service Type, Therapy Type, Technology, Application, Scale, End User, Process Stage - Global Forecast to 2030 - Product Image

Cell & Gene Therapy Biomanufacturing CDMO Market by Service Type, Therapy Type, Technology, Application, Scale, End User, Process Stage - Global Forecast to 2030

  • Report
  • 188 Pages
  • Global
From
Nucleic Acid Therapeutics CDMO Market Size, Share & Trends Analysis Report By Type, By Service, By End-use, By Application, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Nucleic Acid Therapeutics CDMO Market Size, Share & Trends Analysis Report By Type, By Service, By End-use, By Application, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 170 Pages
  • Global
From

About the Advanced Therapy CDMO Market

The Advanced Therapy CDMO market is a subset of the genomics industry that focuses on the development and manufacturing of cell and gene therapies. These therapies are used to treat a variety of diseases, including cancer, neurological disorders, and rare genetic diseases. Advanced Therapy CDMOs provide services such as process development, analytical testing, and clinical and commercial manufacturing. They also provide support for regulatory filings and clinical trials. Advanced Therapy CDMOs are an important part of the genomics industry, as they enable the development and commercialization of novel therapies. They provide the necessary infrastructure and expertise to bring these therapies to market. Some companies in the Advanced Therapy CDMO market include Lonza, Thermo Fisher Scientific, Catalent, and Fujifilm Diosynth Biotechnologies. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.